ClearPoint Neuro (CLPT) News Today → Urgent Alert: Is the U.S. Implementing a Digital Dollar? (From Gold Gate Capital) (Ad) Free CLPT Stock Alerts $6.40 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 11, 2024 | americanbankingnews.comClearPoint Neuro, Inc. to Post Q2 2024 Earnings of ($0.17) Per Share, B. Riley Forecasts (NASDAQ:CLPT)May 10, 2024 | marketbeat.comQ2 2024 Earnings Estimate for ClearPoint Neuro, Inc. (NASDAQ:CLPT) Issued By B. RileyClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) - Analysts at B. Riley upped their Q2 2024 earnings per share (EPS) estimates for ClearPoint Neuro in a research report issued on Tuesday, May 7th. B. Riley analyst W. Wood now forecasts that the company will earn ($0.17) per share for the quarteMay 8, 2024 | msn.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...May 7, 2024 | finance.yahoo.comClearPoint Neuro Inc. Reports Strong Q1 2024 Performance, Surpassing Revenue ExpectationsMay 7, 2024 | msn.comCLPT Stock Earnings: ClearPoint Neuro Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | finance.yahoo.comClearPoint Neuro Reports First Quarter 2024 ResultsMay 2, 2024 | finance.yahoo.comClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in BaltimoreMay 2, 2024 | prnewswire.comSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)May 1, 2024 | investorplace.com7 Penny Stocks That Could Make You a Fortune (If You Dare)April 29, 2024 | finance.yahoo.comClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor AccessoryApril 24, 2024 | finance.yahoo.comClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic SystemApril 23, 2024 | finance.yahoo.comClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024April 22, 2024 | markets.businessinsider.comClearPoint Neuro Poised for Growth: Strong Buy Rating Justified Amidst Market DipApril 19, 2024 | finance.yahoo.comIs There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?April 16, 2024 | globenewswire.comClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN MutationsApril 15, 2024 | marketbeat.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest UpdateClearPoint Neuro, Inc. (NASDAQ:CLPT - Get Free Report) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totalling 1,280,000 shares, a decrease of 8.6% from the March 15th total of 1,400,000 shares. Based on an average daily volume of 152,300 shares, the days-to-cover ratio is currently 8.4 days.April 11, 2024 | investorplace.comThe 3 Most Promising MedTech Stocks to Invest In NowMarch 19, 2024 | globenewswire.comClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC DeficiencyMarch 16, 2024 | msn.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This YearMarch 14, 2024 | finance.yahoo.comClearPoint Neuro Full Year 2023 Earnings: Beats ExpectationsMarch 12, 2024 | finance.yahoo.comClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023March 12, 2024 | globenewswire.comClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 ResultsMarch 11, 2024 | markets.businessinsider.comClearPoint Neuro is about to announce its earnings — here's what Wall Street expectsMarch 11, 2024 | benzinga.comEarnings Outlook For ClearPoint NeuroMarch 11, 2024 | finance.yahoo.comJournal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy SystemMarch 7, 2024 | investorplace.comThe Top 7 Under-$15 Stocks to Buy in March 2024March 1, 2024 | finance.yahoo.comClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024March 1, 2024 | globenewswire.comClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024February 29, 2024 | markets.businessinsider.comClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common StockFebruary 29, 2024 | globenewswire.comClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common StockFebruary 28, 2024 | globenewswire.comClearPoint Neuro Launches Proposed Public Offering of Common StockFebruary 22, 2024 | markets.businessinsider.comClearPoint Neuro’s Strategic Growth and Regulatory Milestones Bolster Buy RatingFebruary 21, 2024 | finance.yahoo.comClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain ModelFebruary 18, 2024 | finance.yahoo.comClearPoint Neuro, Inc.'s (NASDAQ:CLPT) largest shareholders are retail investors with 60% ownership, institutions own 32%February 16, 2024 | finance.yahoo.comClearPoint Neuro, Inc. (CLPT)February 15, 2024 | investorplace.comThe 3 Up-and-Coming Stocks That Could Make Your February UnforgettableFebruary 15, 2024 | investorplace.comThe Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn't Ignore.January 30, 2024 | msn.comClearPoint's (CLPT) Neuro Systems to Boost NeurosurgeriesJanuary 24, 2024 | finance.yahoo.comClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in BuffaloJanuary 23, 2024 | marketwatch.comClearPoint Neuro Gets EU OK For 2 DevicesJanuary 22, 2024 | msn.comClearPoint Neuro receives EU okay for devices, Calif. plantJanuary 22, 2024 | finance.yahoo.comClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to EuropeJanuary 17, 2024 | msn.comClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR SystemJanuary 16, 2024 | msn.comClearPoint Neuro gets FDA clearance for SmartFrame ORJanuary 16, 2024 | markets.businessinsider.comClearPoint Neuro Announces FDA Clearance For SmartFrame OR Stereotactic SystemJanuary 16, 2024 | finance.yahoo.comClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic SystemJanuary 9, 2024 | finanznachrichten.deClearPoint Neuro, Inc.: ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 RevenueJanuary 9, 2024 | msn.comCyclacel Pharmaceuticals, ClearPoint Neuro among healthcare movers Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision. Start streaming it now at no cost here CLPT Media Mentions By Week CLPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLPT News Sentiment▼1.000.54▲Average Medical News Sentiment CLPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLPT Articles This Week▼71▲CLPT Articles Average Week Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Delcath Systems News Today Alpha Tau Medical News Today Quipt Home Medical News Today Accuray News Today CVRx News Today Orchestra BioMed News Today Profound Medical News Today TELA Bio News Today KORU Medical Systems News Today BrainsWay News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLPT) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate Capital348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.